A phase II randomized placebo-controlled trial
Liraglutide in type 2 diabetes mellitus: Clinical pharmacokinetics and pharmacodynamics
Geldenhuys W, Wehrung D, Groshev A, Hirani A, Sutariya V
Os dados de segurana disponveis so preliminares, provenientes de estudos de fase II, e o perfil completo de riscos, contraindicaes e interaes medicamentosas ainda est sendo avaliado nos estudos de fase III em andamento
doi: 10.1080/00325481.2020.1798099 207 PiccoliGFMesquitaLASteinCAzizMZoldanMDegobiNAHet al
Along with the process of -GC synthesis was blocked by BSO, the total contributions of U- 15 N glutamine to GSH was reduced in the established high ACTL6A-expressing PDX tumors, and the levels of [ 15 N]-labeled glutamine and glutamate were thus increased (Fig